Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 39% ± 20% | |
lung | 11 studies | 26% ± 7% | |
peripheral blood | 10 studies | 25% ± 10% | |
eye | 9 studies | 28% ± 13% | |
heart | 4 studies | 25% ± 5% | |
liver | 4 studies | 33% ± 15% | |
intestine | 4 studies | 22% ± 5% | |
adipose | 4 studies | 25% ± 6% | |
bone marrow | 3 studies | 20% ± 3% | |
pancreas | 3 studies | 33% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3985.73 | 1445 / 1445 | 100% | 46.46 | 183 / 183 |
ovary | 100% | 4055.17 | 180 / 180 | 100% | 22.48 | 429 / 430 |
lung | 100% | 3688.19 | 576 / 578 | 100% | 35.51 | 1155 / 1155 |
breast | 100% | 4015.89 | 459 / 459 | 99% | 45.99 | 1111 / 1118 |
brain | 100% | 6102.38 | 2639 / 2642 | 99% | 38.88 | 701 / 705 |
prostate | 100% | 3183.03 | 244 / 245 | 100% | 33.15 | 500 / 502 |
thymus | 100% | 3339.04 | 653 / 653 | 99% | 26.86 | 599 / 605 |
adrenal gland | 100% | 3265.06 | 258 / 258 | 98% | 21.74 | 226 / 230 |
uterus | 100% | 3945.50 | 170 / 170 | 98% | 28.78 | 451 / 459 |
bladder | 100% | 3756.05 | 21 / 21 | 98% | 27.33 | 493 / 504 |
stomach | 100% | 2706.30 | 359 / 359 | 97% | 28.87 | 277 / 286 |
kidney | 100% | 2058.90 | 89 / 89 | 97% | 23.34 | 871 / 901 |
pancreas | 99% | 2380.86 | 324 / 328 | 98% | 22.16 | 174 / 178 |
intestine | 100% | 3660.80 | 966 / 966 | 96% | 24.82 | 507 / 527 |
liver | 100% | 1848.47 | 225 / 226 | 96% | 21.97 | 390 / 406 |
skin | 100% | 4159.04 | 1807 / 1809 | 88% | 29.20 | 416 / 472 |
blood vessel | 100% | 4154.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 7118.88 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2571.67 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 32.57 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.85 | 1 / 1 |
adipose | 100% | 4331.62 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 95% | 3062.33 | 817 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 79% | 12.28 | 23 / 29 |
peripheral blood | 73% | 1560.87 | 676 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 60% | 15.14 | 48 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0034517 | Biological process | ribophagy |
GO_0030242 | Biological process | autophagy of peroxisome |
GO_1903059 | Biological process | regulation of protein lipidation |
GO_0007507 | Biological process | heart development |
GO_0000045 | Biological process | autophagosome assembly |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0034727 | Biological process | piecemeal microautophagy of the nucleus |
GO_0001889 | Biological process | liver development |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_0000422 | Biological process | autophagy of mitochondrion |
GO_0061709 | Biological process | reticulophagy |
GO_0006914 | Biological process | autophagy |
GO_0045793 | Biological process | positive regulation of cell size |
GO_0061723 | Biological process | glycophagy |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0034045 | Cellular component | phagophore assembly site membrane |
GO_0005764 | Cellular component | lysosome |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0005829 | Cellular component | cytosol |
GO_1990316 | Cellular component | Atg1/ULK1 kinase complex |
GO_0000407 | Cellular component | phagophore assembly site |
GO_0031965 | Cellular component | nuclear membrane |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RB1CC1 |
Protein name | RB1 inducible coiled-coil 1 RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200) |
Synonyms | RBICC KIAA0203 |
Description | FUNCTION: Involved in autophagy . Regulates early events but also late events of autophagosome formation through direct interaction with Atg16L1 . Required for the formation of the autophagosome-like double-membrane structure that surrounds the Salmonella-containing vacuole (SCV) during S.typhimurium infection and subsequent xenophagy (By similarity). Involved in repair of DNA damage caused by ionizing radiation, which subsequently improves cell survival by decreasing apoptosis (By similarity). Inhibits PTK2/FAK1 and PTK2B/PYK2 kinase activity, affecting their downstream signaling pathways . Plays a role as a modulator of TGF-beta-signaling by restricting substrate specificity of RNF111 (By similarity). Functions as a DNA-binding transcription factor . Is a potent regulator of the RB1 pathway through induction of RB1 expression . Plays a crucial role in muscular differentiation . Plays an indispensable role in fetal hematopoiesis and in the regulation of neuronal homeostasis (By similarity). . |
Accessions | E5RJC1 H0YC28 E5RH44 H0YC30 ENST00000517963.1 ENST00000519912.1 ENST00000435644.6 [Q8TDY2-2] E5RH63 Q8TDY2 ENST00000025008.10 [Q8TDY2-1] ENST00000518468.1 ENST00000518211.1 ENST00000518710.5 E5RHX0 ENST00000523594.1 |